IP Library Patent Application 19273929
Patent Application
App. No. 19/273,929

Real Time Cleavage Assay

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/273,929
Abstract

A cleavage-based real-time PCR assay method is provided. In general terms, the assay method includes subjecting a reaction mixture comprising a) PCR reagents for amplifying a nucleic acid target, and b) flap cleavage reagents for performing a flap cleavage assay on the amplified nucleic acid target to two sets of thermocycling conditions. No additional reagents are added to the reaction between said first and second sets of cycles and, in each cycle of the second set of cycles, cleavage of a flap probe is measured.

Claims (23)

14 . A method for detecting a target nucleic acid in a sample, comprising:

(a) subjecting a PCR reaction mixture comprising the sample and a flap endonuclease activity to thermocycling conditions that comprise:

i. a first set of 5 to 15 cycles each comprising a denaturation step followed by one or more steps in which all temperatures are in the range of 60° C. to 75° C.; followed by:

ii. a second set of 20 to 50 cycles each comprising a denaturation step followed by one or more steps comprising a temperature that is in the range of 50° C. to 57° C.; and

(b) detecting a fluorescent signal in at least some cycles of the second set, wherein the fluorescent signal is generated by cleavage of a probe by the flap endonuclease activity and indicates the presence of the target nucleic acid,

wherein no additional reagents are added to the PCR reaction mixture between said first and second sets.

15 . The method of claim 14 , wherein the cycles of the second set of 20 to 50 cycles each comprises a temperature that is in the range of 50° C. to 55° C.

16 . The method of claim 14 , wherein the measuring step of (b) comprises measuring cleavage of a fluorophore from an oligonucleotide in each of the second set of 20 to 50 cycles.

17 . The method of claim 14 , wherein the fluorescent signal of (b) indicates presence of a mutation.

18 . The method of claim 14 , wherein step (a) comprises an initial pre-incubation step that activates a thermostable polymerase.

19 . The method of claim 14 , wherein the method further comprises graphing the amount of fluorescent signal that is detected in each of the 20-50 cycles, thereby providing an estimate of the abundance of the target nucleic acid in the reaction mix.

20 . The method of claim 14 , wherein step (b) comprises measuring two fluorescent signals in at least some of cycles of the second set, wherein the fluorescent signals respectively indicate the presence of two different mutations.

21 . A method for detecting a target nucleic acid in a sample, comprising:

(a) subjecting a PCR reaction mixture comprising the sample and a flap endonuclease activity to thermocycling conditions that comprise:

i. a first set of 5 to 15 cycles each comprising a denaturation step followed by one or more steps in which all temperatures are in the range of 65° C. to 75° C.; followed by

ii. a second set of 20 to 50 cycles each comprising a denaturation step followed by one or more steps comprising a temperature that is in the range of 50° C. to 65° C.; and

(b) detecting a fluorescent signal in at least some cycles of the second set, wherein the fluorescent signal is generated by cleavage of a probe by the flap endonuclease activity and indicates the presence of the target nucleic acid, wherein no additional reagents are added to the PCR reaction mixture between said first and second sets.

22 . The method of claim 21 , wherein the cycles of the second set of 20 to 50 cycles each comprises a temperature that is in the range of 50° C. to 55° C.

23 . The method of claim 21 , wherein the measuring step of (b) comprises measuring cleavage of a fluorophore from an oligonucleotide in each of the second set of 20 to 50 cycles.

24 . The method of claim 21 , wherein the fluorescent signal of (b) indicates presence of a mutation.

25 . The method of claim 21 , wherein step (a) comprises an initial pre-incubation step that activates a thermostable polymerase.

26 . The method of claim 21 , wherein the method further comprises graphing the amount of fluorescent signal that is detected in each of the 20-50 cycles, thereby providing an estimate of the abundance of the target nucleic acid in the reaction mix.

27 . The method of claim 21 , wherein step (b) comprises measuring two fluorescent signals in at least some of the cycles of the second set, wherein the fluorescent signals respectively indicate the presence of two different mutations.

Assignments (5)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 73470/0608) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0506 →
PATENT SECURITY AGREEMENT Recorded Nov 5, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073470/0608 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2025
From: EXACT SCIENCES CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 072529/0212 →
MERGER Recorded Oct 9, 2025
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 072529/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2025
From: OLDHAM-HALTOM, REBECCA; ZOU, HONGZHI; LIDGARD, GRAHAM P.; DOMANICO, MICHAEL J.; ALLAWI, HATIM
To: EXACT SCIENCES CORPORATION
Reel/Frame 073068/0416 →